
No data
No data
No data
| CAS Number | 186692-46-6 |
| Catalog Number | AG003U50(AGN-PC-0QFT35) |
| Chemical Name | Roscovitine |
| IUPAC Name | (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol |
| InChI | InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1 |
| InChI Key | BTIHMVBBUGXLCJ-OAHLLOKOSA-N |
| MDL Number | MFCD02266401 |
| Molecular Formula | C19H26N6O |
| Molecular Weight | 354.4493 |
| NSC Number | 701554 |
| SMILES | CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3 |
| UNII | 0ES1C2KQ94 |
| Synonyms | (2R)-2-((6-benzylamino-9-(propan-2-yl)-9h-purin-2-yl)amino)butan-1-ol,
2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine,
CYC 202,
CYC-202,
CYC202,
R roscovitine,
R-roscovitine,
roscovitine,
Seliciclib,
roscovitine,
Seliciclib,
186692-46-6,
R-Roscovitine,
(R)-roscovitine,
CYC202,
CYC-202,
CYC 202,
Roscovitine (Seliciclib,CYC202),
2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine,
UNII-0ES1C2KQ94,
NSC 701554,
AL-39256,
InSolution™ Roscovitine,
CHEMBL14762,
0ES1C2KQ94,
CHEBI:45307,
MFCD02266401,
NSC701554,
NSC-701554,
(2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol,
(2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol,
(R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol,
(2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol,
RRC,
C19H26N6O,
Rosco,
(2R)-2-{[6-(benzylamino)-9-(1-methylethyl)-9H-purin-2-yl]amino}butan-1-ol,
(2R)-2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol,
Seliciclib [INN],
2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine,
BMK1-E12,
1unl,
3ddq,
(2R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol,
(2r)-2-{[6-(benzylamino)-9-isopropyl-9h-purin-2-yl]amino}-1-butanol,
Roscovitine/CYC202,
2a4l,
BiomolKI_000048,
1-Butanol, (2R)-,
ROSCOVITINE(Seliciclib),
BiomolKI2_000054,
M02443,
AC1L4NH4,
AC1Q4VI5,
CBiol_002016,
Lopac0_001102,
SCHEMBL94728,
BSPBio_001078,
KBioGR_000418,
KBioSS_000418,
MLS006011028,
BDBM7533,
cid_160355,
GTPL6035,
Roscovitine, >=98% (TLC),
BCBcMAP01_000013,
CTK4D9313,
KBio2_000418,
KBio2_002986,
KBio2_005554,
KBio3_000795,
KBio3_000796,
AOB2095,
DTXSID20171928,
EX-A052,
BTIHMVBBUGXLCJ-OAHLLOKOSA-N,
BCPP000087,
Bio1_000302,
Bio1_000791,
Bio1_001280,
Bio2_000379,
Bio2_000859,
CC205,
HMS1362F19,
HMS1792F19,
HMS1990F19,
HMS3229N13,
HMS3403F19,
BCP01760,
Roscovitine (Seliciclib, CYC202),
ZINC1649340,
ABP000228,
BS0304,
GP3424,
HSCI1_000092,
s1153,
6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine,
AKOS005146319,
AC-2416,
AN-1311,
CCG-100652,
RL02372,
SB16650,
2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol,
IDI1_002134,
SMP1_000266,
2,6,9-Trisubstituted purine deriv. 28,
NCGC00094374-01,
NCGC00094374-02,
NCGC00094374-03,
NCGC00094374-04,
NCGC00094374-05,
AJ-28787,
BC683378,
HY-30237,
NCI60_036420,
SC-85946,
SMR004702823,
AB1010069,
CYC202, Seliciclib, 186692-46-6,
LS-182554,
RT-015440,
FT-0674460,
SW220195-1,
X7381,
K00020,
S-7720,
692R466,
J-011999,
J-524224,
BRD-K07691486-001-03-1,
BRD-K07691486-001-05-6,
UNII-AIR55KO85E component BTIHMVBBUGXLCJ-OAHLLOKOSA-N,
(2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]-1-butanol,
(2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-purin-2-yl]amino]butan-1-ol,
(R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol,
1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)-, (2R)-,
1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2- yl)amino)-, (R)-,
1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (2R)-,
1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (R)-,
1-Butanol,2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2R)-,
2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]- 9H-purin-2-yl]amino]-(R)-1-butanol,
2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol; 6-(Benzylamino) -2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine,
Seliciclib|||CYC-202|||(2R)-2-[[6-(Benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol,
R roscovitine,
InSolution&trade,
D02TIZ,
D05ADP,
cc-362,
Roscovitine(CYC202,Seliciclib),
KST-1A2714,
KST-1A2715,
AR-1A2673,
AR-1A2674,
CID160355,
CS-0016,
A1723,
A10806,
CYC202, Seliciclib, R-roscovitine, Roscovitine,
C104586,
D000077546,
(2R)-2-((6-benzylamino-9-(propan-2-yl)-9h-purin-2-yl)amino)butan-1-ol,
214916-49-1,
214916-51-5,
2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-(R)-1-butanol,
186692-44-4,
|
| Complexity | 417 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 354.217g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 354.458g/mol |
| Monoisotopic Mass | 354.217g/mol |
| Rotatable Bond Count | 8 |
| Topological Polar Surface Area | 87.9A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.2 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H303+H313+H333-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P280-P301+P312-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

